We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Consolidated Water Co
CWCO
$472M
| $51.6K | 0.05% |
1,762
-879
| -33% | -$27K |
|
752
Altria Group
MO
$122B
| $51.6K | 0.05% |
1,183
-470
| -28% | -$19.5K |
|
753
Trustmark
TRMK
$2.71B
| $51.6K | 0.05% |
+1,835
| New | +$49.5K |
|
754
Oceaneering
OII
$5.19B
| $51.3K | 0.05% |
2,192
+1,124
| +105% | +$23.6K |
|
755
Bio-Rad Laboratories Class A
BIO
$8.47B
| $51.2K | 0.05% |
+148
| New | +$48.7K |
|
756
Teekay Tankers
TNK
$2.63B
| $50.9K | 0.05% |
872
+378
| +77% | +$21.4K |
|
757
Costamare
CMRE
$1.89B
| $50.8K | 0.05% |
4,479
+19
| +0.4% | +$210 |
|
758
Macy's
M
$6.57B
| $50.8K | 0.05% |
+2,539
| New | +$49.1K |
|
759
Eagle Materials
EXP
$6.69B
| $50.5K | 0.05% |
186
+176
| +1,760% | +$41.6K |
|
760
Williams Companies
WMB
$86.6B
| $50.5K | 0.05% |
+1,295
| New | +$46K |
|
|
MRNS
761
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $50.4K | 0.05% |
+5,574
| New | +$54.2K |
|
|
DENN
762
DELISTED
Denny's
DENN
| $50.4K | 0.05% |
5,623
+1,048
| +23% | +$10.3K |
|
763
Pediatrix Medical
MD
$2.15B
| $50.3K | 0.05% |
5,010
-3,184
| -39% | -$29.6K |
|
764
Meta Platforms (Facebook)
META
$1.51T
| $50K | 0.04% |
103
-235
| -70% | -$105K |
|
765
Honda
HMC
$37.8B
| $49.8K | 0.04% |
1,337
-934
| -41% | -$32.1K |
|
766
Littelfuse
LFUS
$10.2B
| $49.7K | 0.04% |
+205
| New | +$49.3K |
|
767
Sphere Entertainment
SPHR
$5.01B
| $49.7K | 0.04% |
1,012
-901
| -47% | -$36.1K |
|
768
Ormat Technologies
ORA
$6.28B
| $49.5K | 0.04% |
+748
| New | +$49.9K |
|
769
Lakeland Financial Corp
LKFN
$1.58B
| $49.4K | 0.04% |
745
-311
| -29% | -$20.1K |
|
770
Mission Produce
AVO
$1.12B
| $49.4K | 0.04% |
4,159
-21,203
| -84% | -$226K |
|
771
Zoom
ZM
$26.7B
| $49.3K | 0.04% |
754
-979
| -56% | -$65.3K |
|
772
Nasdaq
NDAQ
$52.5B
| $49.3K | 0.04% |
781
+769
| +6,408% | +$44.5K |
|
773
Exelixis
EXEL
$14B
| $49.1K | 0.04% |
2,071
+1,746
| +537% | +$38.8K |
|
|
NAPA
774
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $49.1K | 0.04% |
5,278
-7,159
| -58% | -$65.6K |
|
|
CFB
775
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $49.1K | 0.04% |
3,549
+2,294
| +183% | +$30.7K |
|
Similar funds
FCM
CPI
SW
MTIC
KFSC
YCM
SC
WPA
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.